Bellevue Group Ag Regeneron Pharmaceuticals, Inc. Transaction History

Bellevue Group Ag

  • $5.93 Billion
  • Q3 2024

A detailed history of Bellevue Group Ag transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 26,776 shares of REGN stock, worth $18.8 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
26,776
Previous 32,297 17.09%
Holding current value
$18.8 Million
Previous $33.9 Million 17.08%
% of portfolio
0.47%
Previous 0.57%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $5.65 Million - $6.63 Million
-5,521 Reduced 17.09%
26,776 $28.1 Million
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $22.3 Million - $27 Million
25,220 Added 356.37%
32,297 $33.9 Million
Q1 2024

May 15, 2024
SELL
$902.69 - $993.35 $3.28 Million - $3.61 Million
-3,632 Reduced 33.92%
7,077 $6.81 Million
Q4 2023

Feb 14, 2024
SELL
$775.18 - $881.7 $3.28 Million - $3.73 Million
-4,230 Reduced 28.32%
10,709 $9.41 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $961,120 - $1.17 Million
-1,388 Reduced 8.5%
14,939 $12.3 Million
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $707,730 - $839,483
1,011 Added 6.6%
16,327 $11.7 Million
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $246,337 - $299,363
-362 Reduced 2.31%
15,316 $12.6 Million
Q4 2022

Feb 14, 2023
SELL
$705.89 - $766.39 $1.21 Million - $1.31 Million
-1,711 Reduced 9.84%
15,678 $11.3 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $194,001 - $244,820
-338 Reduced 1.91%
17,389 $12 Million
Q2 2022

Aug 11, 2022
SELL
$548.35 - $738.84 $39.8 Million - $53.6 Million
-72,553 Reduced 80.36%
17,727 $10.5 Million
Q1 2022

May 13, 2022
SELL
$595.12 - $698.43 $1.65 Million - $1.94 Million
-2,780 Reduced 2.99%
90,280 $63.1 Million
Q4 2021

Feb 10, 2022
SELL
$543.48 - $670.97 $7.26 Million - $8.96 Million
-13,350 Reduced 12.55%
93,060 $58.8 Million
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $430,522 - $510,720
750 Added 0.71%
106,410 $64.4 Million
Q2 2021

Aug 12, 2021
BUY
$472.8 - $558.54 $33 Million - $39 Million
69,860 Added 195.14%
105,660 $59 Million
Q1 2021

May 12, 2021
BUY
$446.73 - $548.2 $3.62 Million - $4.44 Million
8,100 Added 29.24%
35,800 $16.9 Million
Q4 2020

Feb 16, 2021
BUY
$478.3 - $607.98 $3.68 Million - $4.68 Million
7,700 Added 38.5%
27,700 $13.4 Million
Q3 2020

Nov 16, 2020
SELL
$544.75 - $658.21 $1.69 Million - $2.04 Million
-3,100 Reduced 13.42%
20,000 $11.2 Million
Q2 2020

Aug 13, 2020
BUY
$493.32 - $643.92 $1.97 Million - $2.58 Million
4,000 Added 20.94%
23,100 $14.4 Million
Q1 2020

May 14, 2020
SELL
$336.18 - $494.43 $974,922 - $1.43 Million
-2,900 Reduced 13.18%
19,100 $9.33 Million
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $6.03 Million - $8.28 Million
22,000 New
22,000 $8.26 Million
Q2 2019

Aug 14, 2019
SELL
$299.6 - $414.82 $6.11 Million - $8.46 Million
-20,400 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $1.93 Million - $2.29 Million
5,200 Added 34.21%
20,400 $8.38 Million
Q4 2018

Feb 12, 2019
SELL
$335.82 - $403.04 $3.45 Million - $4.14 Million
-10,280 Reduced 40.35%
15,200 $5.68 Million
Q3 2018

Nov 13, 2018
BUY
$351.14 - $408.51 $2.89 Million - $3.36 Million
8,220 Added 47.62%
25,480 $10.3 Million
Q2 2018

Aug 07, 2018
SELL
$284.6 - $344.99 $2.88 Million - $3.49 Million
-10,120 Reduced 36.96%
17,260 $5.96 Million
Q1 2018

May 09, 2018
SELL
$315.82 - $393.78 $132,644 - $165,387
-420 Reduced 1.51%
27,380 $9.43 Million
Q4 2017

Feb 14, 2018
SELL
$358.63 - $469.95 $860,712 - $1.13 Million
-2,400 Reduced 7.95%
27,800 $10.5 Million
Q3 2017

Nov 13, 2017
BUY
$431.38 - $504.0 $905,898 - $1.06 Million
2,100 Added 7.47%
30,200 $13.5 Million
Q2 2017

Aug 14, 2017
BUY
N/A
28,100
28,100 $13.8 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email